SYNDAX PHARMACEUTICALS INC's ticker is and the CUSIP is 87164F905. A total of 4 filers reported holding SYNDAX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,170,312 | +11083.1% | 80,600 | +16020.0% | 0.00% | – |
| Q2 2023 | $10,465 | +423.2% | 500 | +400.0% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -93.5% | 100 | -92.9% | 0.00% | – |
| Q4 2021 | $31,000 | -75.0% | 1,400 | -78.5% | 0.00% | – |
| Q3 2021 | $124,000 | +490.5% | 6,500 | +441.7% | 0.00% | – |
| Q2 2021 | $21,000 | +133.3% | 1,200 | +200.0% | 0.00% | – |
| Q1 2021 | $9,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q4 2020 | $9,000 | -88.0% | 400 | -92.2% | 0.00% | – |
| Q3 2020 | $75,000 | -81.7% | 5,100 | -81.5% | 0.00% | -100.0% |
| Q2 2020 | $409,000 | -16.7% | 27,600 | -38.4% | 0.00% | -50.0% |
| Q1 2020 | $491,000 | +944.7% | 44,800 | +729.6% | 0.00% | – |
| Q4 2019 | $47,000 | +17.5% | 5,400 | 0.0% | 0.00% | – |
| Q3 2019 | $40,000 | +900.0% | 5,400 | +1250.0% | 0.00% | – |
| Q2 2019 | $4,000 | +100.0% | 400 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | +100.0% | 400 | +33.3% | 0.00% | – |
| Q4 2018 | $1,000 | -99.6% | 300 | -99.0% | 0.00% | -100.0% |
| Q3 2018 | $231,000 | +23000.0% | 28,600 | +28500.0% | 0.00% | – |
| Q2 2018 | $1,000 | -99.7% | 100 | -99.6% | 0.00% | -100.0% |
| Q1 2018 | $323,000 | – | 22,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 100 | $2,000 | 0.00% |
| SIMPLEX TRADING, LLC | 2,800 | $53,000 | 0.00% |
| JANE STREET GROUP, LLC | 15,400 | $296,000 | 0.00% |